Refurbished Medical Devices Market Size, Share, Growth, and Industry Analysis, By Type (Online Sales,Offline Sales), By Application (Hospitals,Ambulatory Care Centers,Diagnostic Imaging Centers), Regional Insights and Forecast to 2035
Refurbished Medical Devices Market Overview
The global Refurbished Medical Devices Market is forecast to expand from USD 22143.6 million in 2026 to USD 23726.87 million in 2027, and is expected to reach USD 41215.1 million by 2035, growing at a CAGR of 7.15% over the forecast period.
The Refurbished Medical Devices Market has been experiencing a significant rise in adoption across global healthcare systems, supported by demand from hospitals, diagnostic centers, and ambulatory care facilities. In 2024, nearly 42.7% of diagnostic imaging equipment purchased globally came from refurbished channels. Ultrasound machines, MRI systems, and CT scanners collectively accounted for 58.4% share of all refurbished medical devices in circulation.
Refurbished surgical equipment also saw accelerated adoption, accounting for 22.1% of total installations across hospitals and outpatient centers. This growth is linked to the availability of advanced certified refurbished equipment at 35–50% lower cost compared to new devices, making them accessible for smaller healthcare facilities worldwide.
The United States dominates the Refurbished Medical Devices Market with a share of 46% of global refurbished imaging sales in 2024. More than 1,400 hospitals and 2,100 diagnostic centers in the U.S. utilized refurbished medical systems, especially imaging modalities and patient monitoring equipment.
Within the U.S., refurbished MRI scanners accounted for 18.5% of total MRI installations, while refurbished ultrasound devices reached 27.3% share across hospitals and outpatient clinics. With healthcare budgets under pressure, refurbished devices allowed U.S. healthcare providers to save nearly 48% in acquisition costs, fueling their continued growth across regional and private healthcare systems.
Key Findings
- Key Market Driver: Over 62% of hospitals globally are adopting refurbished devices, driven by demand for cost reduction, with 41% growth in refurbished imaging installations recorded since 2021.
- Major Market Restraint: Around 37% of healthcare facilities remain hesitant due to perceived device quality risks, with 29% citing regulatory compliance challenges.
- Emerging Trends: Approximately 54% of refurbished devices sold in 2024 were certified by OEMs, with 22% growth in third-party refurbishment providers.
- Regional Leadership: North America accounted for 38.1% share, followed by Europe at 26.7%, and Asia-Pacific at 23.9%.
- Competitive Landscape: The top 10 players together held 72% of the market, with GE Healthcare and Philips Healthcare contributing over 34% combined share.
- Market Segmentation: Imaging equipment dominated with 42.7% share, followed by surgical devices at 22.1%, and monitoring devices at 18.9%.
- Recent Development: In 2024, refurbished dialysis equipment installations increased by 17%, while refurbished cath lab systems recorded 19% growth in emerging markets.
Refurbished Medical Devices Market Latest Trends
The Refurbished Medical Devices Market is increasingly driven by the global need for cost containment and improved healthcare accessibility. In 2024, approximately 48% of hospitals in developing countries adopted refurbished systems to expand diagnostic and treatment capacity. Diagnostic imaging remained the fastest-growing category, representing 42.7% of the refurbished market share, with refurbished CT scanners and MRI units witnessing adoption growth of 24% year-on-year. Ultrasound systems dominated among imaging equipment, accounting for 28% of refurbished installations globally.
Emerging economies in Asia and Africa increasingly relied on refurbished devices, with nearly 56% of private diagnostic centers in India depending on refurbished imaging tools. In Europe, 31% of public hospitals integrated refurbished surgical devices and monitoring systems to offset financial constraints. North America demonstrated higher preference for certified OEM refurbished devices, where 54% of refurbished equipment sold in 2024 was manufacturer-certified. Sustainability also influenced adoption trends, with refurbished devices contributing to a 30% reduction in medical e-waste, aligning with green healthcare initiatives.
Refurbished Medical Devices Market Dynamics
The Refurbished Medical Devices Market Dynamics highlight the growing significance of cost-effective procurement models and regional adoption patterns. In 2024, North America commanded approximately 38.1% market share, with over 1,400 hospitals purchasing refurbished imaging, surgical, and monitoring equipment—a 21% increase over 2023 and average budget savings near 48%. Imaging devices remain top sellers, with hospitals representing 41.3% share of the refurbished segment. Around 70% of all refurbished imaging devices are sold in the U.S. (46%) and Europe (24%).
DRIVER
"Rising demand for affordable medical equipment"
The primary driver of the Refurbished Medical Devices Market is the rising demand for affordable healthcare technology. Globally, 62% of hospitals in developing regions reported limited budgets for new equipment, leading them to opt for refurbished solutions. For example, refurbished ultrasound devices are available at 40–60% lower price points, enabling widespread adoption across outpatient and rural facilities. In 2024 alone, refurbished dialysis machines increased installations by 17% worldwide, ensuring broader access to essential therapies. With healthcare systems targeting cost savings of 30–50%, refurbished devices deliver significant efficiency benefits while maintaining compliance with international standards.
RESTRAINT
"Quality and regulatory concerns"
A major restraint is the concern regarding device quality and regulatory compliance. Approximately 37% of healthcare institutions globally expressed hesitancy in using refurbished devices due to risks of shorter operational lifespan. In Europe, 29% of providers cited challenges related to regulatory compliance and certification standards. Additionally, limited access to OEM-certified refurbishment in some regions restricted adoption, as 22% of devices sold in emerging markets lacked adequate post-sales support. These regulatory inconsistencies and consumer concerns create a restraint on overall market expansion despite cost benefits.
OPPORTUNITY
"Rising demand in emerging markets"
The opportunity lies in the rapid adoption of refurbished medical devices in Asia-Pacific, Africa, and Latin America. In 2024, nearly 56% of diagnostic imaging centers in India used refurbished machines, while 41% of African private hospitals purchased refurbished monitoring systems. Refurbished devices also provided opportunities for smaller hospitals, with adoption increasing by 32% in rural facilities across Asia. As global demand for affordable medical infrastructure rises, refurbished devices offer a crucial opportunity for healthcare providers to expand access without significantly increasing financial burdens.
CHALLENGE
"Lack of standardization in refurbishment processes"
One of the key challenges remains the lack of standardization in refurbishment processes. Around 28% of refurbished devices in circulation globally in 2024 were serviced by uncertified vendors, raising concerns of safety and operational risks. This inconsistency created difficulties for healthcare facilities to ensure uniform quality assurance. While 54% of equipment was OEM-certified, the remaining segment faced scrutiny over patient safety and compliance. The challenge also extended to servicing and spare parts availability, with 25% of hospitals in Africa reporting delays in maintenance support for refurbished equipment.
Refurbished Medical Devices Market Segmentation
The Refurbished Medical Devices Market is segmented by type and application, each showing distinct adoption trends. By type, offline sales channels dominated with 61.8% share in 2024, reflecting hospitals’ preference for direct OEM-certified vendors, while online sales accounted for 38.2% share, supported by growing e-commerce adoption among diagnostic centers. The offline segment recorded more than 1,900 hospitals purchasing refurbished systems, while online platforms reported a 19% increase in transactions year-on-year.
BY TYPE
Online Sales: Online sales accounted for 38.2% of the refurbished medical devices market in 2024, supported by increased e-commerce adoption. Nearly 62% of small diagnostic centers reported purchasing refurbished imaging systems online, with MRI and ultrasound machines being the top choices. Competitive pricing and transparent vendor ratings made online platforms a trusted channel for procurement, leading to a 19% rise in online transactions compared to the previous year.
The Online Sales segment: is projected to reach USD 12,514.27 million by 2034, representing 32.5% share, advancing at a CAGR of 7.9%, supported by the growing role of e-commerce in hospital and diagnostic equipment procurement.
Top 5 Major Dominant Countries in the Online Sales Segment
- United States: The U.S. will achieve USD 4,102.38 million by 2034, holding 32.7% share, driven by adoption of e-commerce channels in refurbished imaging and monitoring devices, progressing steadily at a CAGR of 8.1%.
- Germany: Germany is expected to reach USD 1,114.76 million by 2034, capturing 8.9% share, driven by hospitals and diagnostic centers increasingly procuring refurbished imaging systems online, supported by a steady CAGR of 7.2%.
- United Kingdom: The UK will secure USD 1,026.76 million by 2034, translating to 8.2% share, fueled by e-market platforms for refurbished surgical and dialysis equipment, growing at a CAGR of 7.3%.
- China: China is projected at USD 1,627.34 million by 2034, accounting for 13.0% share, supported by rapid growth in digital health platforms and e-commerce integration, advancing strongly at a CAGR of 8.0%.
- India: India will record USD 950.39 million by 2034, nearly 7.6% share, supported by SME-led e-commerce expansion for refurbished medical imaging and dialysis machines, with adoption expanding at a CAGR of 8.4%.
Offline Sales: Offline sales held 61.8% share of the market, with hospitals and large institutions preferring direct OEM-certified refurbishers. In 2024, more than 1,900 hospitals acquired refurbished devices directly through offline channels, with emphasis on CT, X-ray, and surgical systems. Strong after-sales support and warranty coverage led to 72% of OEM-certified purchases being made offline.
The Offline Sales segment: is projected to reach USD 25,950.59 million by 2034, representing 67.5% share, advancing at a CAGR of 6.9%, supported by hospitals’ preference for OEM-certified refurbishers and direct vendor procurement for large-scale medical installations.
Top 5 Major Dominant Countries in the Offline Sales Segment
- United States: The U.S. will secure USD 7,971.52 million by 2034, accounting for 30.7% share, driven by strong reliance on direct vendor channels and OEM-certified refurbished imaging, with growth steady at a CAGR of 6.8%.
- France: France is forecasted at USD 1,987.49 million by 2034, representing 7.7% share, supported by adoption in public hospitals and health facilities preferring offline refurbished procurement, advancing at a CAGR of 6.7%.
- Japan: Japan will achieve USD 1,818.54 million by 2034, nearly 7.0% share, driven by refurbished MRI and dialysis machine procurement via direct OEM refurbishment channels, with demand rising at a CAGR of 6.9%.
- China: China will capture USD 2,548.47 million by 2034, translating into 9.8% share, supported by hospital reliance on offline refurbishers for large-scale imaging installations, progressing at a CAGR of 7.2%.
- Canada: Canada is expected to hold USD 1,424.63 million by 2034, capturing 5.5% share, supported by refurbished monitoring systems sold through offline vendors, advancing at a CAGR of 6.6%.
BY APPLICATION
Hospitals: Hospitals accounted for 41.3% share of refurbished device adoption in 2024. Approximately 1,400 hospitals in North America and 1,200 hospitals in Europe used refurbished imaging and monitoring devices to optimize budgets.
Hospitals: are projected to reach USD 15,937.64 million by 2034, holding 41.4% share, expanding at a CAGR of 7.0%, supported by large-scale adoption of refurbished imaging, surgical, and dialysis equipment across advanced healthcare networks.
Top 5 Major Dominant Countries in the Hospitals Segment
- United States: Will capture USD 4,698.67 million by 2034, securing 29.5% share, driven by hospital adoption of refurbished CT and MRI systems, advancing at a CAGR of 7.1%.
- Germany: Will secure USD 1,386.79 million by 2034, with 8.7% share, supported by refurbished surgical and patient monitoring systems, growing at a CAGR of 6.8%.
- United Kingdom: Will achieve USD 1,245.08 million by 2034, holding 7.8% share, driven by refurbished dialysis and monitoring equipment, expanding at a CAGR of 6.9%.
- China: Will capture USD 1,923.22 million by 2034, nearly 12.0% share, led by hospital integration of refurbished ultrasound and CT scanners, growing at a CAGR of 7.3%.
- India: Will secure USD 1,121.05 million by 2034, translating into 7.0% share, fueled by demand for refurbished imaging in public hospitals, advancing at a CAGR of 7.5%.
- Ambulatory Care Centers: Ambulatory centers represented 28.6% of the market, with refurbished ultrasound and dialysis machines being most in demand. In Asia, 36% of ambulatory facilities reported exclusive use of refurbished devices.
Ambulatory care centers: are projected to reach USD 10,828.49 million by 2034, accounting for 28.2% share, progressing at a CAGR of 7.4%, supported by refurbished ultrasound and dialysis systems adopted for budget efficiency.
Top 5 Major Dominant Countries in the Ambulatory Segment
- United States: Will secure USD 3,039.97 million by 2034, representing 28.1% share, driven by demand for refurbished patient monitoring systems, advancing at a CAGR of 7.6%.
- France: Will capture USD 897.59 million by 2034, nearly 8.3% share, supported by ambulatory use of refurbished surgical devices, growing at a CAGR of 7.1%.
- Japan: Will record USD 821.36 million by 2034, representing 7.6% share, with adoption of refurbished dialysis and ultrasound systems, advancing at a CAGR of 7.2%.
- China: Will achieve USD 1,242.43 million by 2034, accounting for 11.5% share, fueled by expansion of refurbished diagnostic imaging, progressing at a CAGR of 7.7%.
- India: Will secure USD 732.64 million by 2034, holding 6.8% share, with ambulatory growth in refurbished ultrasound machines, expanding at a CAGR of 7.8%.
Diagnostic Imaging Centers: Diagnostic imaging centers dominated applications with 30.1% share, relying heavily on refurbished CT and MRI systems. In 2024, nearly 2,100 imaging centers in the U.S. alone used refurbished devices for operations.
Diagnostic imaging centers: are projected to reach USD 11,698.73 million by 2034, capturing 30.4% share, advancing at a CAGR of 7.1%, with MRI, CT, and ultrasound machines forming the largest portion of refurbished demand.
Top 5 Major Dominant Countries in the Diagnostic Imaging Segment
- United States: Will achieve USD 3,579.66 million by 2034, holding 30.6% share, supported by refurbished MRI and CT scanner installations, advancing at a CAGR of 7.3%.
- Germany: Will capture USD 1,127.95 million by 2034, with 9.6% share, driven by refurbished diagnostic ultrasound systems, expanding at a CAGR of 6.9%.
- United Kingdom: Will record USD 1,055.11 million by 2034, nearly 9.0% share, supported by refurbished CT and X-ray systems, progressing at a CAGR of 7.0%.
- China: Will secure USD 1,471.39 million by 2034, translating into 12.6% share, with diagnostic centers adopting refurbished MRI and CT devices, growing at a CAGR of 7.4%.
- Japan: Will achieve USD 978.83 million by 2034, holding 8.4% share, supported by refurbished ultrasound and CT scanners, advancing at a CAGR of 7.2%.
Regional Outlook for the Refurbished Medical Devices Market
The Refurbished Medical Devices Market is regionally dominated by North America at 38.1% share, followed by Europe at 26.7%, Asia-Pacific at 23.9%, and Middle East & Africa at 11.3%. The Refurbished Medical Devices Market demonstrates strong regional variations, with North America holding 38.1% global share, Europe at 26.7%, Asia-Pacific at 23.9%, and Middle East & Africa at 11.3% in 2024. North America’s dominance is linked to the U.S., which alone accounted for 46% of global refurbished imaging sales, supported by over 1,400 hospitals and 2,100 diagnostic centers. Europe’s strength came from Germany, the UK, and France, which collectively represented 57% of regional demand, while refurbished imaging systems contributed 43% of installations.
NORTH AMERICA
North America dominated the refurbished medical devices market with 38.1% global share in 2024, supported by high demand from hospitals, diagnostic centers, and ambulatory facilities. The U.S. alone accounted for nearly 46% of global refurbished imaging device installations, making it the single largest contributor. More than 1,400 hospitals across the U.S. integrated refurbished CT, MRI, and ultrasound machines, generating cost savings of up to 48% per purchase.
North America: is projected to hold 38.1% market share by 2034, reaching USD 14,675.12 million, expanding steadily at a CAGR of 7.2%, driven by the rising adoption of refurbished imaging and monitoring devices across hospitals, ambulatory centers, and diagnostic facilities.
North America – Major Dominant Countries
- United States: The United States will achieve USD 10,230.47 million by 2034, commanding 69.6% of the regional share, supported by the widespread adoption of refurbished MRI, CT, and ultrasound equipment across hospitals and diagnostic centers, progressing at a CAGR of 7.3%.
- Canada: Canada is expected to record USD 1,726.15 million by 2034, representing 11.8% of North America’s share, largely driven by refurbished dialysis and patient monitoring devices adopted in public healthcare systems, expanding gradually at a steady CAGR of 7.1%.
- Mexico: Mexico will secure USD 1,425.68 million by 2034, capturing 9.7% of the regional share, with refurbished CT and MRI systems dominating demand in both private and government-funded diagnostic centers, growing at a consistent CAGR of 7.0%.
- Cuba: Cuba is projected to reach USD 147.38 million by 2034, holding 1.0% regional share, supported by refurbished imaging devices deployed primarily in public hospitals and state-run healthcare facilities, with expansion continuing at a CAGR of 6.9%.
- Others (Caribbean): The Caribbean nations collectively are forecasted at USD 145.44 million by 2034, contributing 1.0% share of the region, where refurbished diagnostic imaging devices are gradually being integrated into smaller healthcare facilities, advancing at a steady CAGR of 6.8%.
EUROPE
Europe accounted for 26.7% share of the global refurbished medical devices market in 2024, with Germany, the UK, and France representing over 57% of the region’s adoption. Refurbished imaging equipment accounted for 43% of total refurbished device installations in Europe, with MRI scanners and ultrasound machines being the most demanded. Germany led the market with 21% of the regional share, supported by advanced hospital refurbishment programs and demand for diagnostic imaging.
Europe: is projected to capture 26.7% of the global market by 2034, reaching USD 10,275.13 million, expanding at a CAGR of 6.9%, driven by the rising integration of refurbished imaging, dialysis, and monitoring devices in public hospitals and private diagnostic centers across the continent.
Europe – Major Dominant Countries
- Germany: Germany will achieve USD 2,158.37 million by 2034, representing 21% of the regional share, supported by demand for refurbished MRI and ultrasound equipment, widely deployed in hospitals and university research facilities, advancing steadily at a CAGR of 6.9%.
- United Kingdom: The UK is forecasted at USD 1,849.52 million by 2034, nearly 18% of Europe’s share, fueled by refurbished dialysis machines and surgical devices integrated into public healthcare systems, progressing at a CAGR of 6.8%.
- France: France will capture USD 1,439.21 million by 2034, securing 14% share, with refurbished imaging systems and patient monitoring devices leading hospital installations, expanding consistently at a CAGR of 6.7%.
- Italy: Italy will reach USD 1,027.51 million by 2034, representing 10% of Europe’s market, with refurbished patient monitors and ultrasound systems gaining traction in regional healthcare institutions, growing at a CAGR of 6.8%.
- Spain: Spain is expected to secure USD 822.11 million by 2034, holding 8% of regional share, driven by private diagnostic centers adopting refurbished CT and X-ray devices, advancing steadily at a CAGR of 6.6%.
ASIA-PACIFIC
Asia-Pacific held 23.9% share of the global refurbished medical devices market in 2024, with China and India emerging as dominant markets. Together, they accounted for 61% of the region’s refurbished demand, particularly in diagnostic imaging and dialysis systems. China led with 32% of regional share, fueled by rapid adoption of refurbished CT scanners and ultrasounds in provincial hospitals.
Asia-Pacific: will account for 23.9% share of the global market by 2034, projected at USD 9,204.10 million, advancing at a CAGR of 7.6%, supported by rapid adoption of refurbished imaging, dialysis, and monitoring devices in emerging healthcare systems and expanding diagnostic infrastructure.
Asia – Major Dominant Countries
- China: China will secure USD 2,945.11 million by 2034, representing 32% of Asia’s share, as refurbished CT and ultrasound devices are widely adopted across provincial hospitals and urban diagnostic centers, expanding rapidly at a CAGR of 7.7%.
- India: India is forecasted at USD 2,669.19 million by 2034, capturing 29% share, with refurbished imaging systems accounting for over half of diagnostic center equipment installations, progressing strongly at a CAGR of 7.8%.
- Japan: Japan will reach USD 1,380.61 million by 2034, nearly 15% of the regional share, supported by refurbished MRI scanners and dialysis machines gaining strong presence in advanced hospitals, growing steadily at a CAGR of 7.4%.
- South Korea: South Korea is projected at USD 1,196.53 million by 2034, accounting for 13% of Asia-Pacific’s share, with refurbished surgical equipment and patient monitoring devices leading demand, expanding at a CAGR of 7.3%.
- Singapore: Singapore will record USD 644.66 million by 2034, capturing 7% of the regional share, driven by private hospitals adopting refurbished diagnostic imaging and monitoring systems, advancing at a CAGR of 7.5%.
MIDDLE EAST & AFRICA
The Middle East & Africa refurbished medical devices market accounted for 11.3% global share in 2024, led by the UAE, Saudi Arabia, and South Africa. UAE captured 26% of the region’s share, with government smart healthcare programs boosting demand for refurbished imaging and monitoring equipment. Saudi Arabia followed with 22% share, largely driven by Vision 2030 healthcare reforms and hospital modernization.
Middle East & Africa: is projected to hold 11.3% of the global refurbished medical devices market by 2034, reaching USD 4,310.51 million, expanding at a CAGR of 6.8%, supported by increasing healthcare modernization programs and demand for cost-efficient equipment across the region.
Middle East & Africa – Major Dominant Countries
- UAE: The UAE is expected to achieve USD 1,120.73 million by 2034, capturing 26% of the regional share, with refurbished imaging and monitoring devices widely adopted in hospitals, growing at a steady CAGR of 6.9%.
- Saudi Arabia: Saudi Arabia will secure USD 948.31 million by 2034, representing 22% share, fueled by Vision 2030-driven healthcare reforms and demand for refurbished hospital-grade imaging systems, progressing at a CAGR of 6.7%.
- South Africa: South Africa is forecasted at USD 775.89 million by 2034, accounting for 18% of the region’s share, with ambulatory centers adopting refurbished ultrasound and patient monitoring equipment, advancing at a CAGR of 6.8%.
- Egypt: Egypt will capture USD 689.68 million by 2034, representing 16% share, led by refurbished dialysis machines and imaging devices used in public hospitals, growing steadily at a CAGR of 6.6%.
- Nigeria: Nigeria is projected at USD 465.90 million by 2034, holding 10% of the regional market, supported by private diagnostic centers adopting refurbished imaging systems, expanding consistently at a CAGR of 6.7%.
List of Top Refurbished Medical Devices Companies
- GE Healthcare
- Johnson & Johnson
- Agiliti
- TRACO
- Sanrad Medical Systems
- Whittemore Enterprises
- Radiology Oncology Systems
- Everx Pvt. Ltd
- Soma Technology
- Agito Medical
- Canon
- DMS Topline
- Hilditch Group
- Cambridge Scientific Products
- Block Imaging
- First Source
- Avante
- Siemens Healthcare
- Integrity Medical Systems
- Philips Healthcare
- Fair Medical Co. Ltd
- Biomex Instruments Pvt. Ltd
- Master Medical Equipment
GE Healthcare: GE Healthcare leads the market with 18% global share, specializing in refurbished imaging devices, supplying over 2,000 MRI and CT scanners annually, and serving hospitals in more than 65 countries.
Philips Healthcare: Philips Healthcare holds 16% share, focusing on refurbished ultrasound and monitoring systems, with installations in over 1,500 hospitals worldwide and certified refurbishment centers operating in 40 global markets.
Investment Analysis and Opportunities
Investments in the Refurbished Medical Devices Market are growing rapidly, as healthcare providers seek cost-effective ways to modernize medical infrastructure. In 2024, over 62% of hospitals worldwide invested in refurbished medical imaging, patient monitoring, and surgical devices. Diagnostic imaging remained the most attractive segment, representing 42.7% share of investment. Investors also directed funds into refurbished dialysis systems, which saw installation increases of 17% globally.
Emerging economies presented significant opportunities, with 41% of African hospitals and 56% of diagnostic centers in India using refurbished devices. Private equity investments in third-party refurbishment facilities expanded capacity by 23% in 2024. With refurbished devices costing 35–50% less than new equipment, investments are delivering substantial cost savings to healthcare systems. Expansion of warranty-based service models added confidence, with 65% of buyers in 2024 citing extended service contracts as a deciding factor in investment decisions.
New Product Development
Innovation in the Refurbished Medical Devices Market is focused on increasing device safety, standardization, and sustainability. In 2024, OEM-certified refurbished ultrasound devices accounted for 28% of total refurbished sales, reflecting stronger acceptance. Refurbished CT scanners and MRI units integrated upgraded digital imaging modules, enhancing diagnostic accuracy and aligning with hospital IT systems.
Manufacturers also introduced eco-certified refurbishment processes, contributing to 30% reduction in medical e-waste globally. Advanced refurbishment centers deployed AI-driven quality checks, reducing defect risks by 22%. In patient monitoring systems, refurbished devices incorporated connectivity features, enabling integration with hospital digital platforms, representing 19% growth in adoption.
The development of global refurbishment certification programs in 2024 standardized processes across Europe, Asia, and North America, improving market confidence. Approximately 54% of refurbished devices sold in 2024 were backed by OEM-issued certification, enhancing quality perception. Sustainability initiatives also gained prominence, with hospitals reporting nearly 25% cost reduction on waste disposal through refurbished device use.
Five Recent Developments
- In 2023, GE Healthcare supplied 1,000 refurbished MRI scanners to global hospitals, representing a 22% increase over the prior year.
- Philips Healthcare launched eco-certified refurbished ultrasound devices in 2024, reducing e-waste by 18%.
- Siemens Healthcare expanded its European refurbishment center in 2024, increasing production by 25%.
- In 2024, refurbished dialysis machines saw 17% installation growth across Asia-Pacific.
- In 2025, Johnson & Johnson refurbished surgical devices adoption increased by 19%, with higher penetration in ambulatory care centers.
Report Coverage of Refurbished Medical Devices Market
The Refurbished Medical Devices Market Report provides comprehensive coverage of product categories, applications, sales channels, and regional performance. The study highlights that refurbished imaging equipment led the market with 42.7% share, followed by surgical devices (22.1%) and patient monitoring (18.9%). Hospitals accounted for the largest application share at 41.3%, while diagnostic centers followed with 30.1%.
By type, offline sales dominated with 61.8%, while online procurement gained traction, representing 38.2% share in 2024. Regional analysis showed North America leading with 38.1% market share, Europe holding 26.7%, and Asia-Pacific contributing 23.9%. The Middle East & Africa demonstrated promising growth with 11.3% share, fueled by hospital modernization projects.
The report also emphasizes vendor landscape insights, with the top 10 companies controlling 72% of the market. GE Healthcare and Philips Healthcare emerged as dominant leaders, with a combined share exceeding 34%. Coverage extends to new product development, investments, sustainability measures, and regional dynamics influencing adoption.
Refurbished Medical Devices Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 22143.6 Million in 2026 |
|
|
Market Size Value By |
USD 41215.1 Million by 2035 |
|
|
Growth Rate |
CAGR of 7.15% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Refurbished Medical Devices Market is expected to reach USD 41215.1 Million by 2035.
The Refurbished Medical Devices Market is expected to exhibit a CAGR of 7.15% by 2035.
GE Healthcare,Johnson & Johnson,Agiliti,TRACO,Sanrad Medical Systems,Whittemore Enterprises,Radiology Oncology Systems,Everx Pvt. Ltd,Soma Technology,Agito Medical,Canon,DMS Topline,Hilditch Group,Cambridge Scientific Products,Block Imaging,First Source,Avante,Siemens Healthcare,Integrity Medical Systems,Philips Healthcare,Fair Medical Co. Ltd,Biomex Istruments Pvt. Ltd,Master Medical Equipment.
In 2025, the Refurbished Medical Devices Market value stood at USD 20665.98 Million.